1 From the Departments of Pediatrics, University of Maryland, The Johns Hopkins University, Baltimore, Maryland; Department of Pediatrics, Rhode Island Hospital, Brown University, Providence, Rhode Island; Department of Child Health, University of Newcastle Upon Tyne, The Medical School, United Kingdom; and Department of Child Health, Institute of Child Health, London, United Kingdom
A discussion meeting was held on October 17, 1989, to address the current status of the definition of significant hypoglycemia in infancy, especially in the normal- and low-birth-weight neonate.
Robert Schwartz introduced the complexity of the problem by indicating the multiple variables (duration, severity, cerebral blood flow, rates of glucose uptake, availability of alternate substrates, oxygen, etc) in equating a plasma glucose value with neurodevelopmental consequences.
Marvin Cornblath reviewed the various definitions of hypoglycemic blood sugar levels reported since 1911 which depend upon the method of blood sugar analysis, clinical recognition and concerns. Severe symptomatic hypoglycemia that persisted or recurred was first reported in neonates in 1937. Lower blood sugar levels, documented since the 1920s in both full-term and premature newborns, had been considered physiologic. The recognition of transient significant hypoglycemia first in symptomatic and then in asymptomatic small-for-gestational-age, neonates required new definitions in the 1960s. These definitions were later modified as changes in treating both the mother in labor and at delivery and the neonate occurred. Intensive care and the survival of very-low-birth-weight newborns have compounded the problem of definition. Currently methods are available to correlate plasma glucose concentrations and glucose metabolism in vivo in the brain with specific neurologic dysfunctions. This should permit a better definition of the continuum of significant hypoglycemia than has been available before.
William Hay analyzed studies of the various rapid bedside glucose oxidase stick techniques used to screen for blood glucose concentrations. He concluded that their dependence on the hematocrit, their requirements for precision in performance and timing, great variance (±5 to 15 mg/dL), and lack of reproducibility, especially at blood glucose values less than 50 mg/dL, made their use in the neonate unsatisfactory (whether read by eye or by meter).
Submitted on November 27, 1989
This article has been cited by other articles:
![]() |
A. L. Alkalay, L. Flores-Sarnat, H. B. Sarnat, S. J. Farber, and C. F. Simmons Plasma glucose concentrations in profound neonatal hypoglycemia. Clinical Pediatrics, July 1, 2006; 45(6): 550 - 558. [Abstract] [PDF] |
||||
![]() |
N. Boluyt, A. van Kempen, and M. Offringa Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics, June 1, 2006; 117(6): 2231 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Lonlay, A. Simon-Carre, M.-J. Ribeiro, N. Boddaert, I. Giurgea, K. Laborde, C. Bellanne-Chantelot, V. Verkarre, M. Polak, J. Rahier, et al. Congenital Hyperinsulinism: Pancreatic [18F]Fluoro-L-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography and Immunohistochemistry Study of DOPA Decarboxylase and Insulin Secretion J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 933 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Giurgea, K. Laborde, G. Touati, C. Bellanne-Chantelot, M.-C. Nassogne, C. Sempoux, F. Jaubert, N. Khoa, V. Chigot, J. Rahier, et al. Acute Insulin Responses to Calcium and Tolbutamide Do Not Differentiate Focal from Diffuse Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 925 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reid, S. McQuillan, and J. Losek Hypoglycemia Complicating Dehydration due to Acute Gastroenteritis Clinical Pediatrics, September 1, 2003; 42(7): 641 - 646. [Abstract] [PDF] |
||||
![]() |
W. W. Hay Jr and M. Cornblath Historical Perspectives: Transient Symptomatic Neonatal Hypoglycemia NeoReviews, January 1, 2003; 4(1): e1 - 5. [Full Text] [PDF] |
||||
![]() |
R. M. Cowett The Infant of the Diabetic Mother NeoReviews, September 1, 2002; 3(9): e173 - 189. [Full Text] [PDF] |
||||
![]() |
K K Diwakar and M V Sasidhar Plasma glucose levels in term infants who are appropriate size for gestation and exclusively breast fed Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2002; 87(1): F46 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ebbesen, A. Joergensen, E. Hoseth, P.-H. Kaad, M. Moeller, V. Holsteen, and M. Rix Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 124F - 129. [Abstract] [Full Text] |
||||
![]() |
M. Cornblath, J. M. Hawdon, A. F. Williams, A. Aynsley-Green, M. P. Ward-Platt, R. Schwartz, and S. C. Kalhan Controversies Regarding Definition of Neonatal Hypoglycemia: Suggested Operational Thresholds Pediatrics, May 1, 2000; 105(5): 1141 - 1145. [Abstract] [Full Text] |
||||
![]() |
A Aynsley-Green, K Hussain, J Hall, J M Saudubray, C Nihoul-Fékété, P De Lonlay-Debeney, F Brunelle, T Otonkoski, P Thornton, and K J Lindley Practical management of hyperinsulinism in infancy Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 98F - 107. [Abstract] [Full Text] |
||||
![]() |
M. Cornblath, R. Schwartz, A. Lucas, and R. Morley Outcome of neonatal hypoglycaemia BMJ, January 16, 1999; 318(7177): 194a - 194. [Full Text] |
||||
![]() |
E Stenninger, R Flink, B Eriksson, and C Sahlèn Long term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy Arch. Dis. Child. Fetal Neonatal Ed., November 1, 1998; 79(3): 174F - 179. [Abstract] [Full Text] |
||||
![]() |
L. P. Halamek, D. A. Benaron, and D. K. Stevenson Neonatal Hypoglycemia, Part I: Background and Definition Clinical Pediatrics, December 1, 1997; 36(12): 675 - 680. [Abstract] [PDF] |
||||